AEG-1 positively regulates the expression of FANCD2 and FANCI, which regulates DNA damage by platinum compounds, and knocking out AEG-1 in endometrial cancer cells significantly increased their sensitivity to cisplatin [184]. This evidence concerns the gene FANCD2 and endometrial cancer.